Public funding and pricing

The Norwegian Medical Products Agency is responsible for assessing the cost-effectivness of and setting maximum prices for prescription-only-medicines.

Horizon scanning and assessment requests
Health technology assessments
Pricing of medicines

Shortcuts

Submission of documentation for single technology assessment of pharmaceuticals
Maximum price

News

See all news

FINOSE becomes Joint Nordic HTA-Bodies, JNHB

Published: 04/06/2024

FINOSE now includes all Nordic countries

Published: 23/04/2024

Switching between a reference product and a biosimilar

Published: 29/10/2017

Updated: 23/10/2023

Closer Nordic co-operation regarding more paediatric medicines

Published: 30/05/2023

Updated: 23/10/2023

External pages

Nye metoder: The national system of managed introduction of new methods

Public funding and pricing

Shortcuts

Related pages

Fees

The Norwegian health care system and pharmaceutical system

News

External pages